To assess the activation status of the infiltrated CD8+ T cells in the tumor microenvironment, we performed coimmunofluorescence analyses of CD8 and Granzyme B, the latter a marker indicative of activated CD8+ T cells (45, 46), on tumor sections. The gene discussed is GZMB; the disease is neoplasm.